Choong Ang Vaccine Laboratory Co. Ltd - Asset Resilience Ratio

Latest as of March 2026: 9.65%

Choong Ang Vaccine Laboratory Co. Ltd (072020) has an Asset Resilience Ratio of 9.65% as of March 2026. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing.

Liquid Assets

₩12.01 Billion
≈ $8.14 Million USD Cash + Short-term Investments

Total Assets

₩124.42 Billion
≈ $84.32 Million USD All company assets

Resilience Assessment

Low
Financial Resilience Level

Asset Resilience Ratio Trend (2014–2025)

This chart shows how Choong Ang Vaccine Laboratory Co. Ltd's Asset Resilience Ratio has changed over time. Check 072020 PP&E to net assets ratio to assess the company's strategic physical and investment asset allocation.

Liquid Assets Composition Over Time

This chart breaks down Choong Ang Vaccine Laboratory Co. Ltd's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For market capitalisation and broader financial context, see Choong Ang Vaccine Laboratory Co. Ltd market capitalisation.

Current Liquid Assets Breakdown

Component Amount % of Total Assets
Cash & Equivalents ₩0.00 0%
Short-term Investments ₩12.01 Billion 9.65%
Total Liquid Assets ₩12.01 Billion 9.65%

Asset Resilience Insights

  • Limited Liquidity: Choong Ang Vaccine Laboratory Co. Ltd maintains only 9.65% of assets in liquid form.
  • This low level may indicate efficient asset utilization but could pose risks during economic downturns.
  • The company has significant short-term investments, indicating active treasury management.

Choong Ang Vaccine Laboratory Co. Ltd Industry Peers by Asset Resilience Ratio

Compare Choong Ang Vaccine Laboratory Co. Ltd's asset resilience ratio with other companies in the same industry.

Company Industry Asset Resilience Ratio
Takeda Pharmaceutical Company Limited
F:TKDA
Drug Manufacturers - Specialty & Generic 0.69%
Shandong Buchang Pharmaceuticals Co Ltd
SHG:603858
Drug Manufacturers - Specialty & Generic 3.47%
Beijing Sun Novo Pharmaceutical Research Co Ltd
SHG:688621
Drug Manufacturers - Specialty & Generic 2.04%
Guizhou Xinbang Pharmaceutical Co Ltd
SHE:002390
Drug Manufacturers - Specialty & Generic 0.01%
Guangdong Lifestrong Pharmacy Co. Ltd.
SHE:301111
Drug Manufacturers - Specialty & Generic 7.85%
Jw Pharmac
KO:001060
Drug Manufacturers - Specialty & Generic 3.65%
Kamada
TA:KMDA
Drug Manufacturers - Specialty & Generic 0.00%
Samjin Pharm
KO:005500
Drug Manufacturers - Specialty & Generic 0.25%

Annual Asset Resilience Ratio for Choong Ang Vaccine Laboratory Co. Ltd (2014–2025)

The table below shows the annual Asset Resilience Ratio data for Choong Ang Vaccine Laboratory Co. Ltd.

Year Asset Resilience Ratio (%) Liquid Assets Total Assets Change
2025-12-31 11.21% ₩13.77 Billion
≈ $9.33 Million
₩122.82 Billion
≈ $83.23 Million
-12.44pp
2024-12-31 23.65% ₩29.15 Billion
≈ $19.76 Million
₩123.28 Billion
≈ $83.54 Million
+0.72pp
2023-12-31 22.93% ₩27.42 Billion
≈ $18.58 Million
₩119.59 Billion
≈ $81.05 Million
+7.27pp
2022-12-31 15.66% ₩17.98 Billion
≈ $12.19 Million
₩114.86 Billion
≈ $77.84 Million
-3.35pp
2021-12-31 19.00% ₩21.47 Billion
≈ $14.55 Million
₩112.95 Billion
≈ $76.55 Million
-2.68pp
2020-12-31 21.69% ₩22.77 Billion
≈ $15.43 Million
₩104.98 Billion
≈ $71.14 Million
+0.22pp
2019-12-31 21.47% ₩20.73 Billion
≈ $14.05 Million
₩96.57 Billion
≈ $65.44 Million
-3.62pp
2018-12-31 25.09% ₩24.27 Billion
≈ $16.45 Million
₩96.74 Billion
≈ $65.56 Million
+6.69pp
2017-12-31 18.40% ₩15.02 Billion
≈ $10.18 Million
₩81.62 Billion
≈ $55.32 Million
-8.91pp
2016-12-31 27.31% ₩20.09 Billion
≈ $13.61 Million
₩73.54 Billion
≈ $49.84 Million
+19.11pp
2015-12-31 8.21% ₩5.10 Billion
≈ $3.45 Million
₩62.10 Billion
≈ $42.09 Million
+2.19pp
2014-12-31 6.02% ₩3.65 Billion
≈ $2.47 Million
₩60.60 Billion
≈ $41.07 Million
--
pp = percentage points

About Choong Ang Vaccine Laboratory Co. Ltd

KQ:072020 Korea Drug Manufacturers - Specialty & Generic
Market Cap
$57.71 Million
₩85.16 Billion KRW
Market Cap Rank
#21304 Global
#1198 in Korea
Share Price
₩9200.00
Change (1 day)
+1.10%
52-Week Range
₩8780.00 - ₩10140.00
All Time High
₩30815.73
About

Choong Ang Vaccine Laboratory Co., Ltd. engages in the research, development, manufacturing, and sale of animal vaccines in South Korea, Asia, Africa, and the United States. It offers swine, poultry, cattle, canine, feline, wild boar, and raccoon vaccines under the SuiShot, PoulShot, BoviShot, CaniShot, and FeliShot brands. The company was founded in 1968 and is headquartered in Daejeon, South Ko… Read more